PDE3 inhibition with enoximone as first‐line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report

Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both thera...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Lee, Robin, Peels, Barbara, Koopman‐Esseboom, Corine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224780/
https://www.ncbi.nlm.nih.gov/pubmed/28096983
http://dx.doi.org/10.1002/ccr3.748
Descripción
Sumario:Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first‐line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both therapeutics.

Ejemplares similares